Fisher Clinical Services is a pivotal player in the Pharmaceutical industry, operating under the BioPharma Services Division of Thermo Fisher Scientific. With a profound dedication to advancing global health, safety, and cleanliness, the company prides itself on providing unparalleled scientific service. As a key subsidiary of Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader with annual revenues of $17 billion and an extensive workforce of over 50,000 employees across 50 countries, the company has positioned itself to enable clients to contribute to a healthier and safer world. By catering to over 350,000 customers in sectors including pharmaceuticals, biotech, healthcare, clinical diagnostics, academia, research, government, environmental, and industrial process control, Fisher Clinical Services has solidified its influence in diverse scientific domains. Despite the lack of specific details concerning recent investments, the company's robust presence within the industry and its association with the formidable Thermo Fisher Scientific Inc. underlines its potential for sustainable growth and innovation.
There is no investment information
No recent news or press coverage available for Fisher Clinical Services.